Estrogen receptor modulators

Details Estrogen receptor modulators Estrogen receptor modulators

2006-12-19

2006-12-19

Witherspoon, Sikarl A. (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Oxygen containing

C568S330000, C564S271000, C562S469000, C514S641000, C514S680000, C514S784000

Reexamination Certificate

active

07151196

ABSTRACT:
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including: bone loss, bone fractures, osteoporosis, metastatic bone disease, Paget's disease, periodontal disease, cartilage degeneration, endometriosis, uterine fibroid disease, hot flashes, increased levels of LDL cholesterol, cardiovascular disease, impairment of cognitive functioning, age-related mild cognitive impairment, cerebral degenerative disorders, restenosis, gynecomastia, vascular smooth muscle cell proliferation, obesity, incontinence, inflammation, inflammatory bowel disease, irritable bowel syndrome, sexual dysfunction, hypertension, retinal degeneration and cancer, in particular of the breast, uterus and prostate.

REFERENCES:
patent: 4316043 (1982-02-01), Cragoe, Jr. et al.
patent: 4317922 (1982-03-01), Cragoe, Jr. et al.
patent: 4356313 (1982-10-01), Cragoe, Jr. et al.
patent: 4356314 (1982-10-01), Cragoe, Jr. et al.
patent: 4377354 (1983-03-01), Morton
patent: 4604396 (1986-08-01), Cragoe, Jr. et al.
patent: 4675341 (1987-06-01), Cragoe, Jr.
patent: 4704472 (1987-11-01), Conn et al.
patent: 4731470 (1988-03-01), Pietruszkiewicz et al.
patent: 4731471 (1988-03-01), Cragoe, Jr. et al.
patent: 4731472 (1988-03-01), Pietruszkiewicz et al.
patent: 4797391 (1989-01-01), Woltersdorf, Jr. et al.
patent: 4835313 (1989-05-01), Pietruszkiewicz et al.
patent: 6251898 (2001-06-01), Cragoe, Jr. et al.
patent: 2003/0027840 (2003-02-01), Parker et al.
patent: WO01/82923 (2001-11-01), None
Cragoe, EJ et al., Journal of Medicinal Chemistry, vol. 29, pp. 825-841 (1986), “Agents for the Treatment of Brain Edema. 2.[(2,3,9,9a-Tetrahydro-3-oxo-9a-sbustituted-1H-flouren-7-yl)oxy]alkanoic Acids and Some of Their Analogues”.

Affiliated with

Also associated with

Rating

Estrogen receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Estrogen receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogen receptor modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3703824